Standard BioTools Inc. (LAB) Earnings History
Annual and quarterly earnings data from 2006 to 2025
Loading earnings history...
LAB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LAB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 49.9% | -109.3% | -87.8% |
| 2024 | 48.3% | -100.5% | -79.6% |
| 2023 | 47.4% | -72.0% | -70.2% |
| 2022 | 37.8% | -118.6% | -194.1% |
| 2021 | 53.1% | -51.7% | -45.4% |
Download Data
Export LAB earnings history in CSV or JSON format
Free sign-in required to download data
Standard BioTools Inc. (LAB) Earnings Overview
As of May 8, 2026, Standard BioTools Inc. (LAB) reported trailing twelve-month net income of $78M, reflecting +61.5% year-over-year growth. The company earned $0.20 per diluted share over the past four quarters, with a net profit margin of -87.8%.
Looking at the long-term picture, LAB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$16M in fiscal 2013.
Standard BioTools Inc. maintains positive profitability with a gross margin of 49.9%, operating margin of -109.3%, and net margin of -87.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AZTA (-$178M net income, -9.4% margin), NTRA (-$208M net income, -9.0% margin), PACB (-$546M net income, -341.5% margin), LAB has room to improve margins relative to the peer group. Compare LAB vs AZTA →
LAB Earnings vs Peers
Earnings metrics vs comparable public companies
LAB Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$75M | +46.1% | -$93M | $-0.20 | -87.8% | -109.3% |
| 2024 | -$139M | -86.0% | -$175M | $-0.52 | -79.6% | -100.5% |
| 2023 | -$75M | +60.7% | -$77M | $-0.94 | -70.2% | -72.0% |
| 2022 | -$190M | -220.9% | -$116M | $-2.43 | -194.1% | -118.6% |
| 2021 | -$59M | -11.7% | -$67M | $-0.78 | -45.4% | -51.7% |
| 2020 | -$53M | +18.2% | -$51M | $-0.74 | -38.4% | -36.9% |
| 2019 | -$65M | -9.8% | -$52M | $-0.97 | -55.3% | -44.2% |
| 2018 | -$59M | +2.5% | -$48M | $-1.49 | -52.2% | -42.6% |
| 2017 | -$61M | +20.3% | -$58M | $-1.84 | -59.4% | -57.3% |
| 2016 | -$76M | -42.5% | -$73M | $-2.62 | -72.8% | -70.1% |
See LAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LAB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LAB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLAB — Frequently Asked Questions
Quick answers to the most common questions about buying LAB stock.
Is LAB growing earnings?
LAB EPS is $0.20, with earnings growth accelerating to +61.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $78M.
What are LAB's profit margins?
Standard BioTools Inc. net margin is -87.8%, with operating margin at -109.3%. Below-average margins reflect competitive or cost pressures.
How consistent are LAB's earnings?
LAB earnings data spans 2006-2025. The accelerating earnings trend is +61.5% YoY. Historical data enables comparison across business cycles.